See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Tuberculosis (TB), one of the leading infectious disease killers ...

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...

A new study published in the American Society for Microbiology journal Microbiology Spectrum demonstrates that a novel semi-synthetic compound can be derived from natural compounds to produce potent ...

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent, affecting more than 10 million people each year and caused and estimated 1.25 million deaths in 2023. 1,2 While ...

Drug-resistant tuberculosis represents a major obstacle to global TB control, with outcomes that consistently fall short of WHO targets. Multidrug-resistant tuberculosis (MDR-TB) and extensively ...

A new study uncovers vulnerabilities in drug-resistant TB, offering hope for improved treatments. Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works ...

Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs, while others may warrant more aggressive therapy, according to the findings of a new ...

Only four out of 10 patients with extensively drug-resistant tuberculosis (TB) in Europe achieved successful treatment outcomes, a rate markedly lower than that for other forms of drug-resistant TB ...

Tuberculosis (TB) remains one of the leading causes of mortality from a single infectious agent worldwide and continues to pose a major public health ...

Drug-resistant Mycobacterium tuberculosis emerges through spontaneous chromosomal mutations in key genes such as rpoB and katG, which confer resistance to frontline drugs but often impair bacterial ...